Literature DB >> 9632719

Recruitment of human TBP selectively activates RNA polymerase II TATA-dependent promoters.

B Majello1, G Napolitano, P De Luca, L Lania.   

Abstract

An increasing body of evidence suggests that eukaryotic activators stimulate polymerase II transcription by facilitating the assembly of the functional basal machinery at the promoter. Here we describe experiments that provide added support for the idea that recruitment of TATA-binding protein (TBP) is a rate-limiting step for transcription activation in mammalian cells. We found that, in human cell lines, recruitment of TBP to a promoter, as a GAL4-TBP fusion protein, can provide a substantial activation of transcription. Activation mediated by the hTBP, tethered to promoter DNA, is strictly dependent upon the presence of a functional TATA element, and it directs faithful transcription initiation. Interestingly, GAL4-hTBP activation was not observed from initiator (Inr) -dependent TATA-less promoters. These results suggest that TBP binding to DNA is not a rate-limiting step for the initial stages of TFIID recruitment to initiator-dependent TATA-less promoters. Finally, we provide evidence that synergy between GAL4-hTBP and defined transcription domains is restricted to activators, such as VP16 and Tat, which are likely to function at steps subsequent to the TFIID recruitment. These findings strengthen the idea that recruitment of TBP represents an important mechanism of activation of TATA-dependent promoters, and on the other hand, they suggest that TBP-DNA interactions are largely dispensable for specific transcription of initiator dependent TATA-less promoters.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9632719     DOI: 10.1074/jbc.273.26.16509

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  Transcriptional cofactor CA150 regulates RNA polymerase II elongation in a TATA-box-dependent manner.

Authors:  C Suñé; M A Garcia-Blanco
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

2.  Transcriptional activation by artificial recruitment in mammalian cells.

Authors:  J Nevado; L Gaudreau; M Adam; M Ptashne
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

3.  The coactivator dTAF(II)110/hTAF(II)135 is sufficient to recruit a polymerase complex and activate basal transcription mediated by CREB.

Authors:  E A Felinski; P G Quinn
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-30       Impact factor: 11.205

Review 4.  Regulation of HIV-1 transcription.

Authors:  K A Roebuck; M Saifuddin
Journal:  Gene Expr       Date:  1999

5.  Role of the TATA binding protein-transcription factor IIB interaction in supporting basal and activated transcription in plant cells.

Authors:  S Pan; E Czarnecka-Verner; W B Gurley
Journal:  Plant Cell       Date:  2000-01       Impact factor: 11.277

6.  cis-regulatory logic of short-range transcriptional repression in Drosophila melanogaster.

Authors:  Meghana M Kulkarni; David N Arnosti
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

7.  Artificial recruitment of TFIID, but not RNA polymerase II holoenzyme, activates transcription in mammalian cells.

Authors:  D R Dorris; K Struhl
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

8.  Abnormal expression of TFIIIB subunits and RNA Pol III genes is associated with hepatocellular carcinoma.

Authors:  Junxia Lei; Songlin Chen; Shuping Zhong
Journal:  Liver Res       Date:  2017-09-09

9.  TBP is differentially regulated by c-Jun N-terminal kinase 1 (JNK1) and JNK2 through Elk-1, controlling c-Jun expression and cell proliferation.

Authors:  Shuping Zhong; Jody Fromm; Deborah L Johnson
Journal:  Mol Cell Biol       Date:  2006-10-30       Impact factor: 4.272

Review 10.  Dysregulation of the basal RNA polymerase transcription apparatus in cancer.

Authors:  Megan J Bywater; Richard B Pearson; Grant A McArthur; Ross D Hannan
Journal:  Nat Rev Cancer       Date:  2013-05       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.